Wednesday, August 19, 2026

BTC $68,626 ▲ 2.50%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$68,626+2.50%ETH$2,080+3.90%SOL$82.35+6.00%XRP$1.07+3.50%LINK$9.92+3.80%ADA$0.182+1.10%S&P 5007,724+0.42%Nasdaq26,375+0.32%Dow53,498+0.29%RUT3,047+0.95%TNX4.66%−0.98%TYX5.21%−1.51%FVX4.36%−0.16%IRX3.71%+0.00%VIX15.17−4.23%GOLD$4,543.30+2.78%SILVER$65.68+2.57%OIL$85.32+1.50%DXY98.91−0.75%NVDA$219.23−0.23%AAPL$316.44+2.07%TSLA$346.87+2.97%META$551.84+1.50%MSFT$486.27+0.96%AMZN$264.28+1.86%GOOGL$345.21+0.29%Fear & Greed46 — FearBTC$68,626+2.50%ETH$2,080+3.90%SOL$82.35+6.00%XRP$1.07+3.50%LINK$9.92+3.80%ADA$0.182+1.10%S&P 5007,724+0.42%Nasdaq26,375+0.32%Dow53,498+0.29%RUT3,047+0.95%TNX4.66%−0.98%TYX5.21%−1.51%FVX4.36%−0.16%IRX3.71%+0.00%VIX15.17−4.23%GOLD$4,543.30+2.78%SILVER$65.68+2.57%OIL$85.32+1.50%DXY98.91−0.75%NVDA$219.23−0.23%AAPL$316.44+2.07%TSLA$346.87+2.97%META$551.84+1.50%MSFT$486.27+0.96%AMZN$264.28+1.86%GOOGL$345.21+0.29%Fear & Greed46 — Fear

Tag

moderna

1 article

Research & Analysis1h ago

Merck, Moderna's mRNA Melanoma Vaccine Succeeds in Phase 3 Trial

Intismeran, combined with Keytruda, reduced melanoma recurrence—the first neoantigen vaccine to clear a late-stage randomized trial.